This inventor holds 1 USPTO granted patent. Top assignee: Ludwig-Maximilians-Universitat München. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Tina Romer: Innovator in Cell Cycle Detection
Introduction
Tina Romer is a distinguished inventor based in Munich, Germany. She has made significant contributions to the field of cellular biology, particularly in the detection and visualization of the cell cycle in living cells. Her innovative work has implications for understanding cellular processes and developing new therapeutic strategies.
Latest Patents
Tina Romer holds a patent for her invention titled "Detection and visualization of the cell cycle in living cells." This invention relates to a nucleic acid molecule that encodes a polypeptide specifically binding to proliferating cell nuclear antigen (PCNA). The patent also includes a vector comprising the nucleic acid molecule, a host cell containing the nucleic acid or vector, and methods for detecting the amount and location of PCNA in living cells. Additionally, her invention provides a method for screening compounds that affect the cell cycle.
Career Highlights
Tina Romer is affiliated with Ludwig-Maximilians-Universität München, where she conducts her research and contributes to the academic community. Her work has garnered attention for its innovative approach to studying the cell cycle, which is crucial for understanding cell proliferation and its implications in cancer research.
Collaborations
Tina has collaborated with notable colleagues, including Ulrich Rothbauer and Heinrich Leonhardt. These collaborations have enhanced her research and contributed to advancements in the field of cellular biology.
Conclusion
Tina Romer's contributions to the detection and visualization of the cell cycle in living cells exemplify her innovative spirit and dedication to scientific advancement. Her work not only furthers our understanding of cellular processes but also opens new avenues for research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile